Patent · US Active

Molecules

US10381110B2 · kind B2 · utility

0Cited by
0References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 31, 2015
Grant dateAug 13, 2019
Priority date
Expiry dateApr 5, 2037

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG16C20/70
  • WIPO fieldComputer technology
  • WIPO sectorElectrical engineering

Abstract

A method for computational drug design using an evolutionary algorithm, comprises evaluating virtual molecules according to vector distance (VD) to at least one achievement objective that defines a desired ideal molecule. In one method the invention comprises defining a set of n achievement objectives (OA1-n), where n is at least one; defining a population (PG=0) of at least one molecule; selecting an initial population (Pparent) of at least one molecule (I1-In) from the population (PG=0); and evaluating members (I1-In) of the initial population (Pparent) against at least one of the n achievement objectives (OA1-x), where x is from 1 to n.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.